Search

PROCEPT BioRobotics Corp

Suletud

SektorTervishoid

19.16 -1.49

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.97

Max

19.37

Põhinäitajad

By Trading Economics

Sissetulek

-27M

-58M

Müük

11M

94M

Aktsiakasum

-0.47

Kasumimarginaal

-61.905

Töötajad

888

EBITDA

5.1M

-24M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+15.47% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

3. nov 2026

Turustatistika

By TradingEconomics

Turukapital

150M

1.2B

Eelmine avamishind

20.65

Eelmine sulgemishind

19.16

Uudiste sentiment

By Acuity

50%

50%

120 / 339 Pingereas Healthcare

PROCEPT BioRobotics Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. sept 2026, 20:10 UTC

Macro Event

Procept Biorobotics Corp is trading modestly higher, following the Federal Reserve's 25 basis point rate hike amid ongoing inflation concerns and market volatility.

15. sept 2026, 23:21 UTC

Procept Biorobotics Corp shares are higher in after-market trading, despite broader market pressures from rising Treasury yields. No specific news was identified.

11. sept 2026, 20:08 UTC

Procept Biorobotics Corp is higher today, recovering from an earlier dip. The stock remains below its 20-day moving average after three lower closes.

10. sept 2026, 20:31 UTC

Procept Biorobotics Corp shares are higher in after-market hours following increased trading, reversing a trend of declines over the past three sessions.

9. sept 2026, 20:07 UTC

News

Procept Biorobotics shares are declining amid a class action lawsuit alleging misleading sales practices and inflated financial reporting.

8. sept 2026, 20:03 UTC

News

Procept Biorobotics Corp shares are lower as multiple securities class action lawsuits allege misleading inventory and sales practices, impacting investor sentiment.

4. sept 2026, 20:02 UTC

Procept Biorobotics shares are higher today, reflecting overall market strength since Thursday's close. No specific company news was identified to explain the movement.

3. sept 2026, 20:07 UTC

News

Procept Biorobotics shares decline amid a class action lawsuit alleging misleading sales figures and unsustainable inventory levels. The stock pulled back from earlier session highs.

2. sept 2026, 20:01 UTC

News

Procept Biorobotics Corp shares are higher today, reaching a peak cumulative return despite a class action lawsuit from Kaplan Fox & Kilsheimer LLP.

1. sept 2026, 20:04 UTC

News

Procept Biorobotics Corp shares are lower amid a class action lawsuit alleging misleading sales performance and concerns over excess inventory levels.

28. aug 2026, 19:46 UTC

Procept Biorobotics Corp shares are higher since Thursday's close, despite earlier declines during the session. No specific news was identified for today's movement.

26. aug 2026, 19:26 UTC

News

Procept Biorobotics faces a class action lawsuit alleging securities fraud related to inflated handpiece sales, contributing to a decline in shares during Wednesday's session.

25. aug 2026, 19:46 UTC

Procept Biorobotics shares are higher today amid favorable market conditions, including lower crude oil prices and decreasing Treasury yields. No specific company news was identified.

24. aug 2026, 19:36 UTC

News

Procept Biorobotics faces multiple class action lawsuits alleging securities fraud, contributing to negative sentiment as shares trade lower today.

21. aug 2026, 23:26 UTC

Procept Biorobotics shares are higher in after-market trading, amid a broader market recovery following recent geopolitical tensions and their impact on energy prices.

20. aug 2026, 20:06 UTC

News

Shares of Procept Biorobotics Corp are lower following a class action lawsuit alleging false sales and revenue statements, impacting investor sentiment amid negative earnings reports.

19. aug 2026, 19:26 UTC

News

Procept Biorobotics faces a class action lawsuit from Kaplan Fox & Kilsheimer LLP but shares are trading higher during Wednesday's session.

18. aug 2026, 19:16 UTC

Procept Biorobotics Corp shares are higher, trading near the upper end of their one-month range, despite pulling back from earlier session highs.

17. aug 2026, 19:56 UTC

News

Procept Biorobotics faces downward pressure amid class action lawsuits alleging securities fraud, contributing to negative sentiment and a decline since Friday's close.

14. aug 2026, 19:46 UTC

News

Procept Biorobotics faces class action lawsuits alleging securities fraud, leading shares to decline during Friday's session after earlier reaching a high.

13. aug 2026, 20:06 UTC

Procept Biorobotics Corp is gaining during Thursday's session, following strong momentum and peaking at 7.26% earlier, despite a pullback in recent trading.

12. aug 2026, 20:01 UTC

News

Procept Biorobotics shares are lower amid a class action lawsuit alleging securities fraud related to undisclosed inventory issues and misleading sales practices.

11. aug 2026, 20:02 UTC

Procept Biorobotics Corp shares are higher today, marking the seventh consecutive session of gains. No specific news was identified to explain the increase.

10. aug 2026, 19:53 UTC

Procept Biorobotics Corp shares are higher, supported by reduced Fed rate hike expectations following Friday's weaker jobs report. The stock remains above its 20-day moving average.

7. aug 2026, 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

6. aug 2026, 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

5. aug 2026, 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

4. aug 2026, 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

3. aug 2026, 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

31. juuli 2026, 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

Võrdlus sarnastega

Hinnamuutus

PROCEPT BioRobotics Corp Prognoos

Hinnasiht

By TipRanks

15.47% tõus

12 kuu keskmine prognoos

Keskmine 22.286 USD  15.47%

Kõrge 28 USD

Madal 19 USD

Põhineb 10 Wall Streeti analüütiku instrumendi PROCEPT BioRobotics Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

10 ratings

3

Osta

6

Hoia

1

Müü

Sentiment

By Acuity

120 / 339 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.